Research · Sep 3, 2026
[CE] Celanese Thesis 2026: Acetyl Chain DuPont M&M Drives Engineered Materials Capital Return
Celanese Corporation (NYSE: CE) FY2025 revenue ~$9.85-10.30B (-7-12%) with adj. EPS ~$3.85-5.25 reflecting continued post-2024 ~$9.85-10.30B aggregate Acetyl Chain + Engineered Materials revenue (~$3.85-4.05B aggregate Acetyl Chain + ~$5.65-5.95B aggregate Engineered Materials + ~$0.35-0.45B aggregate Other) under continued President + CEO Scott Richardson since January 2025 (~9-month tenure as Celanese CEO; selected post-January 2025 succeeded Lori Ryerkerk retirement amid post-November 2022 DuPont M&M integration challenges). One of the largest US specialty Acetyl Chain + Engineered Materials chemicals companies. Founded 1918 as American Cellulose & Chemical Manufacturing Company (~107-year heritage; selected pioneer Acetic Acid + Cellulose Derivatives specialty; selected post-1987 Celanese AG German parent); selected post-January 2005 NYSE IPO post-Hoechst AG demerger; selected post-2005-2024 ~$15B+ cumulative tuck-in M&A platform expansion (Acetex Pacific 2011 + Next Generation Composites 2018 + November 2022 ~$11B+ DuPont Mobility & Materials acquisition); selected post-2022 DuPont M&M integration challenges + post-2024 dividend cut from $11.00 to ~$2.80; selected post-January 2025 Scott Richardson CEO appointment; selected post-2024 Acetate Tow exit + Engineered Materials Joint Venture monetization. Headquartered in Irving Texas; ~13,000-14,000 employees globally with global Acetyl Chain + Engineered Materials manufacturing footprint. Two primary segments: Engineered Materials ~58%+ ($5.65-5.95B), Acetyl Chain ~38%+ ($3.85-4.05B), Other ~3-5% ($0.35-0.45B). Geographic mix: North America ~35%+ + Europe ~30% + Asia Pacific ~30% + selected various aggregate ~5%. Acetyl Chain Specialty Chemicals pipeline (~$3.85-4.05B): ~$3.85-4.05B Acetyl Chain revenue (~38%+); selected primary post-1918 Acetic Acid + VAM + Emulsion Polymers + Cellulose Derivatives + Acetate Tow; selected ~$1,400-1,600 Acetic Acid price per tonne; selected ~25-30% global Acetic Acid market share; selected ~2-3Mt annual Acetic Acid + VAM capacity; selected post-2024 Acetate Tow exit progression. Engineered Materials + DuPont M&M Integration pipeline: ~$5.65-5.95B Engineered Materials revenue (~58%+); selected primary post-November 2022 ~$11B+ DuPont M&M acquisition (Nylon Polyamide + Acetal POM + LCP + PPS + Long Fiber Reinforced Thermoplastics); selected Automotive + Medical + Consumer Electronics + Industrial end-markets; selected post-2024 ~$200-300M annual DuPont M&M cost synergies (run-rate target by FY2027). President + CEO Scott Richardson since January 2025 (~9-month tenure); CFO Chuck Kyrish. Capital position: ~$2.80 aggregate annual dividend (~60%+ aggregate payout ratio; ~4.0-5.0% aggregate dividend yield; post-2024 cut from $11.00 reflecting post-2022 DuPont M&M leverage); minimal opportunistic buybacks; aggregate capital return ~$305-330M FY2025; net leverage ~4.0-4.5x Net Debt/EBITDA (declining as Free Cash Flow + Acetate Tow exit + Engineered Materials JV monetization); investment-grade Baa3/BBB- credit rating; ~109-111M diluted shares; weighted average debt maturity ~6-7 years. FY2026 thesis: Acetyl Chain Specialty Chemicals pipeline + Engineered Materials + DuPont M&M Integration pipeline + ~$200-300M aggregate annual cost synergies + Acetate Tow exit + Engineered Materials Joint Venture monetization + post-2024 dividend cut. Risks: Eastman Chemical + LyondellBasell + Dow + DuPont + Solvay + Arkema + Lanxess + 3M + Mitsubishi Chemical + Sinopec competitive displacement + Acetic Acid price cycle considerations + Automotive + Medical + Consumer Electronics + Industrial end-market cycle considerations + post-November 2022 DuPont M&M integration execution considerations + Federal Reserve interest rate cycle considerations + post-2024 dividend cut overhang considerations + post-January 2025 Scott Richardson CEO transition continuity considerations.